Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amine oxidase [flavin-containing] B (MAO-B) is an enzyme located on the outer mitochondrial membrane that catalyzes the oxidative deamination of primary and some secondary amines. It plays a significant role in neurotransmitter metabolism, particularly in the brain, and is a therapeutic target for neurological disorders like Parkinson's disease. In rodents, MAO-B is also involved in GABA synthesis in astrocytes. Human MAO-B is a dimeric protein with a covalently bound FAD cofactor and key tyrosyl residues in its active site. Inhibitors targeting MAO-B are used to increase neurotransmitter levels in the brain.
MAO-B inhibitors are used to prevent the breakdown of neurotransmitters, particularly dopamine, by selectively inhibiting the MAO-B enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amine oxidase [flavin-containing] B (MAO-B).